Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...
Despite Pfizer 's ( PFE 0.23%) recent struggles with falling earnings and a bid by an activist investor to unseat its ...
Is the healthcare stock in big trouble and headed for a greater decline, or are investors perhaps a bit too bearish on the ...
Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...
Stocks knocked down in the first ten months of the year often suffer further damage as people sell for tax losses. But they ...
Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...
We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In this article, we are going to ...
After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the ...
BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...
Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, ...